- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: chronic phase CML
Total 47234 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Hodgkin Lymphoma | Myelofibrosis | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Myelodysplastic/Myeloproliferative Neoplasm | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Cytomegalovirus... and other conditionsUnited States
-
Fundacion CRIS de Investigación para Vencer el...Apices Soluciones S.L.; Incyte Biosciences UKActive, not recruitingChronic Myeloid Leukemia, Chronic PhaseSpain
-
Novartis PharmaceuticalsActive, not recruiting
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Myelofibrosis | Mantle Cell LymphomaUnited States
-
Incyte BioSciences FranceCompletedChronic Myeloid LeukemiaFrance
-
GWT-TUD GmbHIncyte Biosciences International SàrlTerminated
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | B Acute Lymphoblastic Leukemia With t(9;22)(q34... and other conditionsUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, United Kingdom
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of MunichActive, not recruiting
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous Leukemia (CML)
-
Ascentage Pharma Group Inc.HealthQuest Pharma Inc.Active, not recruitingChronic Myeloid Leukemia, Chronic PhaseChina
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia, Chronic PhaseChina
-
Ascentage Pharma Group Inc.Active, not recruitingChronic Myeloid Leukemia - Accelerated PhaseChina
-
University of California, San FranciscoAmerican Society of HematologyCompletedChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmUnited States
-
University of RochesterCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedChronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML - Philadelphia Chromosome | CML (Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaGermany
-
Bristol-Myers SquibbICON Clinical ResearchCompletedStudying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY)Chronic Myeloid LeukemiaGermany, United States, Italy, Spain, France, Netherlands, Puerto Rico, Russian Federation
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia Chromosome | Chronic Myeloid Leukemia in Chronic PhaseChina
-
Bristol-Myers SquibbCompleted
-
Ariad PharmaceuticalsCompletedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Japan
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Myeloid LeukemiaItaly
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingChronic Myeloid LeukemiaItaly
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingChronic Myeloid Leukemia | Adults | Chronic PhaseItaly
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingChronic Phase Philadelphia Positive | BCR-ABL Positive | Chronic Myeloid LeukaemiaItaly
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompleted
-
Ariad PharmaceuticalsTerminatedChronic Phase Chronic Myeloid LeukemiaBelgium
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedChronic Myelogenous LeukemiaUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Myeloid LeukemiaUnited States, Belgium, France, Korea, Republic of
-
European LeukemiaNetCompletedChronic Myeloid LeukemiaFrance, Denmark, Norway, Sweden, Czechia, Portugal, Germany, Netherlands, Finland, Greece
-
Gilead SciencesOhio State UniversityTerminatedMyelodysplastic Syndrome | Chronic Myelogenous Leukemia (CML) | Multiple Myeloma (MM) | GVHD (Acute or Chronic) | Acute Myeloid or Lymphoblastic Leukemia (AML or ALL) | Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell) | Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia...United States
-
Novartis PharmaceuticalsTerminatedChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Incyte Biosciences UKCompletedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | Blastic Phase Chronic Myelogenous LeukemiaUnited Kingdom, Ireland
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Philadelphia Positive Chronic Myeloid LeukemiaUnited States, Germany, United Kingdom, France, Italy
-
Novartis PharmaceuticalsCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveUnited States, Germany, United Kingdom, Italy, France, Switzerland
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)Germany, Belgium, France, Italy, Spain, Hungary, Austria, Sweden, Bulgaria, Denmark, Greece, Slovenia, United Kingdom, Czechia, Romania, Serbia, Slovakia, Portugal, Finland, Norway, Poland
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Novartis PharmaceuticalsCompletedHypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myelogenous Leukemia - Chronic PhaseChina
-
Novartis PharmaceuticalsTerminatedCML | Philadelphia Chromosome Positive (Ph+) | Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough LevelsUnited States
-
Mansoura UniversityCompletedCML, Chronic Phase | Chronic Myelogenous Leukemia, BCR-ABL PositiveEgypt
-
University of British ColumbiaBristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsCompletedPhiladelphia Positive (Ph+) Chronic Myelogenous LeukemiaUnited States, France, Korea, Republic of, Thailand, Italy, Netherlands, Turkey, Hungary, Russian Federation, Spain, United Kingdom, Japan, Malaysia
-
University of Michigan Rogel Cancer CenterWithdrawnLeukemia, Chronic MyeloidUnited States
-
Niguarda HospitalCompletedLeukemia, Myeloid, Chronic-PhaseItaly